API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.reuters.com/business/healthcare-pharmaceuticals/gsk-cut-us-prices-advair-valtrex-lamictal-2023-12-22/
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-17-2022-1660735823.pdf
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-declines-approve-eton-pharmas-anti-seizure-drug-2022-05-27/?rpc=401&
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214124
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213949
https://www.nih.gov/news-events/news-releases/study-suggests-no-association-between-antiseizure-drugs-used-during-pregnancy-neurodevelopmental-problems-children-age-2
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-11-2020-1605074117.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-10-2020-1591766845.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-3-2020-1591161308.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207763
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-gets-final-nod-from-usfda-to-market-generic-seizures-drug/articleshow/74948512.cms
https://www.biospace.com/article/fda-action-alert-eton-pharmaceuticals-and-vertex-pharmaceuticals/
https://www.nasdaq.com/articles/fda-says-no-to-epilepsy-drug-imv-advances-covid-19-vaccine-isee-delays-study-2020-03-19
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-19-2020-1582176609.pdf
https://www.pharmacompass.com/pdf/news/taro-pharmaceuticals-usa-inc-issues-voluntary-nationwide-recall-of-lamotrigine-tablets-1578746320.pdf
https://www.pharmacompass.com/pdf/news/union-quimico-farmaceutica-fails-edqm-inspection-1572404101.pdf
https://www.globenewswire.com/news-release/2019/06/27/1875225/0/en/Aucta-Pharmaceuticals-Announces-Licensing-of-Lamotrigine-New-Drug-Application.html
https://www.reuters.com/article/ip-lamictal/class-certified-in-lamictal-antitrust-case-against-gsk-teva-idUSL1N1YI2EC?rpc=401&
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207497
https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=print.getPrintData&ts=8262018111931
https://www.statnews.com/pharmalot/2016/11/07/supreme-court-pay-delay-glaxo-teva/
http://economictimes.indiatimes.com/articleshow/54781720.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://globenewswire.com/news-release/2016/10/11/878734/0/en/Intellipharmaceutics-Signs-an-Exclusive-License-and-Commercial-Supply-Agreement-with-Mallinckrodt.html
http://profit.ndtv.com/news/corporates/article-unichem-recalls-368-bottles-of-anti-epileptic-drug-in-us-report-1470620
https://www.pharmacompass.com/pdf/news/impax-laboratories-inc-issues-voluntary-nationwide-recall-1472536776.pdf
https://www.pharmacompass.com/pdf/news/sciegen-pharmas-generic-lamotrigine-approved-in-us-1466247025.pdf
http://www.in-pharmatechnologist.com/Drug-Delivery/GSK-to-supply-US-with-Ventolin-from-French-plant-after-production-halt-at-Zebulon
http://www.indiainfoline.com/article/news-top-story/dr-reddy-s-gets-tentative-us-fda-nod-for-generic-of-lamictal-115100700312_1.html?
http://blogs.wsj.com/pharmalot/2015/06/26/cash-is-not-always-king-in-pharma-pay-to-delay-deals-appeals-court/
http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2015/05/another-punt-return-resolving-180-day-exclusivity-this-time-a-true-post-mma-case-made-in-the-context.html
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0378-2015&w=01282015&lang=eng
http://medicalxpress.com/news/2014-12-antiepilepsy-drugs-minimal-differences.html